Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952117 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Erythropoietin (EPO) (AA 19-48), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity Chromatography on Protein A
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- N-Term, AA 19-48
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Erythropoietin activates mitochondrial biogenesis and couples red cell mass to mitochondrial mass in the heart.
Transduction of human EPO into human bone marrow mesenchymal stromal cells synergistically enhances cell-protective and migratory effects.
Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Kristensen PL, Pedersen-Bjergaard U, Schalkwijk C, Olsen NV, Thorsteinsson B
European journal of endocrinology 2010 Sep;163(3):391-8
European journal of endocrinology 2010 Sep;163(3):391-8
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
Erythropoietin activates mitochondrial biogenesis and couples red cell mass to mitochondrial mass in the heart.
Carraway MS, Suliman HB, Jones WS, Chen CW, Babiker A, Piantadosi CA
Circulation research 2010 Jun 11;106(11):1722-30
Circulation research 2010 Jun 11;106(11):1722-30
Transduction of human EPO into human bone marrow mesenchymal stromal cells synergistically enhances cell-protective and migratory effects.
Kim MH, Cho GW, Huh YM, Kim SH
Molekuliarnaia biologiia 2010 Jul-Aug;44(4):656-63
Molekuliarnaia biologiia 2010 Jul-Aug;44(4):656-63
Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z, Hodges VM, Dunlop EA, Percy MJ, Maxwell AP, El-Tanani M, Lappin TR
Molecular cancer research : MCR 2010 Apr;8(4):615-26
Molecular cancer research : MCR 2010 Apr;8(4):615-26
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB